Analysts’ Updated EPS Estimates for December 16th (ABNB, ACHR, ACVA, AHT, AMRQ, AMZN, ANGI, ARCT, ASRT, BAM)

Analysts’ updated eps estimates for Monday, December 16th:

Airbnb (NASDAQ:ABNB) had its market perform rating reaffirmed by analysts at JMP Securities.

Archer Aviation (NYSE:ACHR) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $12.50 target price on the stock.

ACV Auctions (NASDAQ:ACVA) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $25.00 price target on the stock.

Ashtead Group (LON:AHT) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 6,800 ($85.86) price target on the stock.

Amaroq Minerals (LON:AMRQ) had its speculative buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 125 ($1.58) target price on the stock.

Amazon.com (NASDAQ:AMZN) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $285.00 target price on the stock.

Angi (NASDAQ:ANGI) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $3.00 target price on the stock.

Arcturus Therapeutics (NASDAQ:ARCT) had its overweight rating reiterated by analysts at Cantor Fitzgerald.

Assertio (NASDAQ:ASRT) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $4.00 target price on the stock.

Brookfield Asset Management (TSE:BAM) (NYSE:BAM) had its buy rating reaffirmed by analysts at UBS Group AG.

BridgeBio Pharma (NASDAQ:BBIO) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $49.00 price target on the stock.

Biomea Fusion (NASDAQ:BMEA) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $40.00 price target on the stock.

BP (LON:BP) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 540 ($6.82) price target on the stock.

CarGurus (NASDAQ:CARG) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $46.00 price target on the stock.

Carisma Therapeutics (NASDAQ:CARM) had its neutral rating reiterated by analysts at HC Wainwright.

Chewy (NYSE:CHWY) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $37.00 target price on the stock.

Checkpoint Therapeutics (NASDAQ:CKPT) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $20.00 price target on the stock.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $87.00 price target on the stock.

CoStar Group (NASDAQ:CSGP) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $90.00 target price on the stock.

Carvana (NYSE:CVNA) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $320.00 price target on the stock.

Sprinklr (NYSE:CXM) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $17.00 price target on the stock.

Digihost Technology (NASDAQ:DGHI) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $2.50 price target on the stock.

1stdibs.Com (NASDAQ:DIBS) had its market perform rating reiterated by analysts at JMP Securities.

eBay (NASDAQ:EBAY) had its market perform rating reaffirmed by analysts at JMP Securities.

Entain (LON:ENT) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a GBX 1,140 ($14.39) target price on the stock.

Etsy (NASDAQ:ETSY) had its market perform rating reiterated by analysts at JMP Securities.

Evoke (LON:EVOK) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 140 ($1.77) price target on the stock.

Expedia Group (NASDAQ:EXPE) had its market perform rating reissued by analysts at JMP Securities.

Grindr (NYSE:GRND) had its market outperform rating reaffirmed by analysts at JMP Securities. The firm currently has a $21.00 price target on the stock.

HashiCorp (NASDAQ:HCP) had its market perform rating reiterated by analysts at JMP Securities.

Hovnanian Enterprises (NYSE:HOV) had its neutral rating reaffirmed by analysts at Wedbush. Wedbush currently has a $155.00 target price on the stock.

IAC (NASDAQ:IAC) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $70.00 target price on the stock.

Innovative Industrial Properties (NYSE:IIPR) had its market perform rating reiterated by analysts at JMP Securities.

Larimar Therapeutics (NASDAQ:LRMR) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $15.00 target price on the stock.

Neurocrine Biosciences (NASDAQ:NBIX) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $190.00 target price on the stock.

Neurocrine Biosciences (NASDAQ:NBIX) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $148.00 target price on the stock.

Neurocrine Biosciences (NASDAQ:NBIX) had its outperform rating reiterated by analysts at William Blair.

Neumora Therapeutics (NASDAQ:NMRA) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $30.00 price target on the stock.

NeuroSense Therapeutics (NASDAQ:NRSN) had its hold rating reissued by analysts at Maxim Group.

Offerpad Solutions (NYSE:OPAD) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $4.50 price target on the stock.

PureTech Health (LON:PRTC) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 455 ($5.74) target price on the stock.

PolyPid (NASDAQ:PYPD) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $14.00 target price on the stock.

Shell (LON:SHEL) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 3,200 ($40.40) target price on the stock.

Spruce Biosciences (NASDAQ:SPRB) had its neutral rating reiterated by analysts at HC Wainwright.

Teleflex (NYSE:TFX) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Vacasa (NASDAQ:VCSA) had its market perform rating reiterated by analysts at JMP Securities.

Viavi Solutions (NASDAQ:VIAV) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Videndum (LON:VID) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 425 ($5.37) target price on the stock.

Viridian Therapeutics (NASDAQ:VRDN) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $34.00 price target on the stock.

W. P. Carey (NYSE:WPC) had its market perform rating reiterated by analysts at JMP Securities.

Xometry (NASDAQ:XMTR) had its market outperform rating reaffirmed by analysts at JMP Securities. JMP Securities currently has a $42.00 target price on the stock.

Clear Secure (NYSE:YOU) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $45.00 target price on the stock.